Dr. Schapira reflects on costs in cancer treatment and how financial hardship is something that must be considered in the treatment plan.
State of Cancer Care in America: 2016 Report Finds Unprecedented Opportunity Amid Profound Turbulence
Cancer care and treatment are developing quickly but face many obstacles. ASCO President Julie Vose, MD, comments on ASCO’s third annual State of Cancer Care in America report.
Research presented this weekend at the 2016 Cancer Survivorship Symposium will address some of the challenges patients face after treatment ends.
Once you have finished cancer treatment, it is impossible to reconstruct the exact life you had prior to diagnosis. Jennifer Titche talks about the challenges she faces as a young breast cancer survivor and how she is building a life with new goals.
Managing both caregiving and work responsibilities can be difficult. Caregivers can also face potential workplace discrimination or financial issues from taking time off work. Joanna Fawzy Morales, Esq., a cancer rights attorney, talks about the legal protections and practical resources available to help caregivers better navigate work and caregiving.
In January, Randy Hillard was part of the U.S. Food and Drug Administration committee that considered the first application for a “biosimilar” medication. In this guest post, he describes patients’ role in the drug approval process and how the committee’s decision could influence cancer care in the future.
In this podcast, experts Charles Ryan, MD, and Thomas Powles, MD, talk about bladder cancer treatment, including some of the new approaches that are being developed.
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.
With open enrollment for the Health Insurance Marketplace set to end on February 15, 2015, get practical advice on how to make sure you receive the care you need at a cost you can afford.
In this podcast, Jeffrey S. Weber, MD, PhD, explains the recent ASCO statement on phase I clinical trials and why these studies are important treatment options to discuss with your doctor.